Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 240

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Fructose and the Metabolic Syndrome: Pathophysiology and Molecular Mechanisms

Rutledge, Angela C., Adeli, Khosrow · 2008 · Nutrition Reviews

Abstract

Emerging evidence suggests that increased dietary consumption of fructose in Western society may be a potentially important factor in the growing rates of obesity and the metabolic syndrome. This review will discuss fructose-induced perturbations in cell signaling and inflammatory cascades in insulin-sensitive tissues. In particular, the roles of cellular signaling molecules including nuclear factor kappa B (NFkB), tumor necrosis factor alpha (TNF-alpha), c-Jun amino terminal kinase 1 (JNK-1), protein tyrosine phosphatase 1B (PTP-1B), phosphatase and tensin homolog deleted on chromosome ten (PTEN), liver X receptor (LXR), farnesoid X receptor (FXR), and sterol regulatory element-binding protein-1c (SREBP-1c) will be addressed. Considering the prevalence and seriousness of the metabolic syndrome, further research on the underlying molecular mechanisms and preventative and curative strategies is warranted.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1753-4887.2007.tb00322.x

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Research works printed but not linked: 61

  1. Amos, 1997, The rising global burden of diabetes and its complications: estimates and projections to the year 2010, Diabet Med, 14, S1
  2. Ludwig, 2004, Programming obesity in childhood, Lancet, 364, S226, 10.1016/S0140-6736(04)16688-9 · DOI
  3. Jurgens, 2005, Consuming fructose-sweetened beverages increases body adiposity in mice, Obes Res, 13, S1146, 10.1038/oby.2005.136 · DOI · Paper page
  4. Basciano, 2005, Fructose, insulin resistance, and metabolic dyslipidemia, Nutr Metab (Lond), 2, S5, 10.1186/1743-7075-2-5 · DOI · Paper page
  5. Nagata, 2004, Single nucleo-tide polymorphism (-468 Gly to A) at the promoter region of SREBP-1c associates with genetic defect of fructose-induced hepatic lipogenesis [corrected], J Biol Chem, 279, S29031, 10.1074/jbc.M309449200 · DOI
  6. Le, 2006, Metabolic effects of fructose, Curr Opin Clin Nutr Metab Care, 9, S469, 10.1097/01.mco.0000232910.61612.4d · DOI · Paper page
  7. Hansen, 2006, Is all fat the same? The role of fat in the pathogenesis of the metabolic syndrome and type 2 diabetes mellitus, Surgery, 139, S711, 10.1016/j.surg.2005.10.018 · DOI
  8. Reynisdottir, 1997, Comparison of hormone-sensitive lipase activity in visceral and subcutaneous human adipose tissue, J Clin Endocrinol Metab, 82, S4162
  9. Kahn, 1992, Alterations in glucose transporter expression and function in diabetes: mechanisms for insulin resistance, J Cell Biochem, 48, S122, 10.1002/jcb.240480203 · DOI
  10. Fried, 1998, Omental and subcutaneous adipose tissues of obese subjects release interleukin-6:depot difference and regulation by glucocorticoid, J Clin Endocrinol Metab, 83, S847
  11. Hotamisligil, 1996, IRS-1 -mediated inhibition of insulin receptor tyrosine kinase activity in TNF-al-pha- and obesity-induced insulin resistance, Science, 271, S665, 10.1126/science.271.5249.665 · DOI · Paper page
  12. Kerouz, 1997, Differential regulation of insulin receptor substrates-1 and -2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of the obese diabetic (ob/ob) mouse, J Clin Invest, 100, S3164, 10.1172/JCI119872 · DOI · Paper page
  13. Shimomura, 2000, Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice, Mol Cell, 6, S77, 10.1016/S1097-2765(05)00010-9 · doi:10.1016/s1097-2765(05)00010-9 · Paper page
  14. Taghibiglou, 2002, Hepatic very low density lipoprotein-ApoB overproduction is associated with attenuated hepatic insulin signaling and overexpression of pro-tein-tyrosine phosphatase 1B in a fructose-fed hamster model of insulin resistance, J Biol Chem, 277, S793, 10.1074/jbc.M106737200 · DOI · Paper page
  15. Wei, 2004, Hepatospecific effects of fructose on c-jun NH2-terminal kinase: implications for hepatic insulin resistance, Am J Physiol Endocrinol Metab, 287, SE926, 10.1152/ajpendo.00185.2004 · DOI
  16. Czech, 1999, Signaling mechanisms that regulate glucose transport, J Biol Chem, 274, S1865, 10.1074/jbc.274.4.1865 · DOI · Paper page
  17. Wolfrum, 2004, Foxa2 regulates lipid metabolism and ketogen-esis in the liver during fasting and in diabetes, Nature, 432, S1027, 10.1038/nature03047 · DOI · Paper page
  18. Wolfrum, 2006, Coactivation of Foxa2 through Pgc-1beta promotes liver fatty acid oxidation and triglyceride/VLDL secretion, Cell Metab, 3, S99, 10.1016/j.cmet.2006.01.001 · DOI · Paper page
  19. Goodyear, 1995, Insulin receptor phosphoryla-tion, insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects, J Clin Invest, 95, S2195, 10.1172/JCI117909 · DOI · Paper page
  20. Goldstein, 1992, Protein-tyrosine phosphatases and the regulation of insulin action, J Cell Biochem, 48, S33, 10.1002/jcb.240480107 · DOI
  21. Qiu, 2004, Hepatic PTP-1B expression regulates the assembly and secretion of apolipoprotein B-containing lipoproteins: evidence from protein tyrosine phosphatase-1 B overexpression, knockout, and RNAi studies, Diabetes, 53, S3057, 10.2337/diabetes.53.12.3057 · DOI
  22. Sasaoka, 2006, Lipid phosphatases as a possible therapeutic target in cases of type 2 diabetes and obesity, Pharmacol Ther, 112, S799, 10.1016/j.pharmthera.2006.06.001 · DOI
  23. Clement, 2001, The lipid phosphatase SHIP2 controls insulin sensitivity, Nature, 409, S92, 10.1038/35051094 · DOI · Paper page
  24. Fukui, 2005, Impact of the liver-specific expression of SHIP2 (SH2-containing inositol 5′-phosphatase 2) on insulin signaling and glucose metabolism in mice, Diabetes, 54, S1958, 10.2337/diabetes.54.7.1958 · DOI
  25. Carlson, 2003, Enhanced basal activation of mito-gen-activated protein kinases in adipocytes from type 2 diabetes: potential role of p38 in the down-regulation of GLUT4 expression, Diabetes, 52, S634, 10.2337/diabetes.52.3.634 · DOI · Paper page
  26. Tsai, 2007, MEK-ERK inhibition corrects the defect in VLDL assembly in HepG2 cells. Potential role of ERK in VLDL-ApoB100 particle assembly, Arterioscler Thromb Vasc Biol, 27, S211, 10.1161/01.ATV.0000249861.80471.96 · DOI
  27. Allister, 2005, Inhibition of microsomal triglyceride transfer protein expression and apolipoprotein B100 secretion by the citrus flavonoid naringenin and by insulin involves activation of the mitogen-activated protein kinase pathway in hepatocytes, Diabetes, 54, S1676, 10.2337/diabetes.54.6.1676 · DOI
  28. Corbould, 2006, Enhanced mitogenic signaling in skeletal muscle of women with polycystic ovary syndrome, Diabetes, 55, S751, 10.2337/diabetes.55.03.06.db05-0453 · DOI · Paper page
  29. Lazar, 2006, The humoral side of insulin resistance, Nat Med, 12, S43, 10.1038/nm0106-43 · DOI
  30. Li, 2003, Innate immunity in the liver, Curr Opin Gastroenterol, 19, S565, 10.1097/00001574-200311000-00009 · DOI
  31. Choi, 2005, Role of inflammation in nonalcoholic steatohepatitis, Curr Opin Gastroenterol, 21, S702, 10.1097/01.mog.0000182863.96421.47 · DOI
  32. Davis, 2000, Signal transduction by the JNK group of MAP kinases, Cell, 103, S239, 10.1016/S0092-8674(00)00116-1 · DOI · Paper page
  33. Nakatani, 2004, Modulation of the JNK pathway in liver affects insulin resistance status, J Biol Chem, 279, S45803, 10.1074/jbc.M406963200 · DOI · Paper page
  34. Kelley, 2004, High dietary fructose induces a hepatic stress response resulting in cholesterol and lipid dysregulation, Endocrinology, 145, S548, 10.1210/en.2003-1167 · DOI · Paper page
  35. Wei, 2005, Fructose selectively modulates c-jun N-terminal kinase activity and insulin signaling in rat primary hepatocytes, J Nutr, 135, S1642, 10.1093/jn/135.7.1642 · DOI
  36. Taghibiglou, 2000, Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance. Evidence for enhanced lipoprotein assembly, reduced intracellu-lar ApoB degradation, and increased microsomal triglyceride transfer protein in a fructose-fed hamster model, J Biol Chem, 275, S8416, 10.1074/jbc.275.12.8416 · DOI · Paper page
  37. Kim, 2006, NF-kappaB and IKK as therapeutic targets in cancer, Cell Death Differ, 13, S738, 10.1038/sj.cdd.4401877 · DOI · Paper page
  38. Boden, 2005, Free fatty acids produce insulin resistance and activate the proin-flammatory nuclear factor-kappaB pathway in rat liver, Diabetes, 54, S3458, 10.2337/diabetes.54.12.3458 · DOI · Paper page
  39. Janabi, 2000, Oxidized LDL-induced NF-kappa B activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients, Arterioscler Thromb Vasc Biol, 20, S1953, 10.1161/01.ATV.20.8.1953 · DOI · Paper page
  40. Rohl, 2004, Conditional disruption of IkappaB kinase 2 fails to prevent obesity-induced insulin resistance, J Clin Invest, 113, S474, 10.1172/JCI200418712 · DOI
  41. Chung, 2005, Conjugated linoleic acid promotes human adipocyte insulin resistance through NFkappaB-de-pendent cytokine production, J Biol Chem, 280, S38445, 10.1074/jbc.M508159200 · DOI · Paper page
  42. Gao, 2003, Aspirin inhibits serine phosphorylation of insulin receptor substrate 1 in tumor necrosis factor-treated cells through targeting multiple serine kinases, J Biol Chem, 278, S24944, 10.1074/jbc.M300423200 · DOI · Paper page
  43. Dietze, 2004, Inhibitor kappaB kinase is involved in the paracrine crosstalk between human fat and muscle cells, Int J Obes Relat Metab Disord, 28, S985, 10.1038/sj.ijo.0802701 · DOI
  44. Sell, 2006, Pathways leading to muscle insulin resistance. The muscle-fat connection, Arch Physiol Biochem, 112, S105, 10.1080/13813450600711540 · DOI · Paper page
  45. Kalaany, 2006, LXRS and FXR: the yin and yang of cholesterol and fat metabolism, Annu Rev Physiol, 68, S159, 10.1146/annurev.physiol.68.033104.152158 · DOI · Paper page
  46. Tobin, 2002, Liver X receptors as insulin-mediating factors in fatty acid and cholesterol biosynthesis, J Biol Chem, 277, S10691, 10.1074/jbc.M109771200 · DOI · Paper page
  47. Cagen, 2005, Insulin activates the rat sterol-regulatory-element-binding protein 1c (SREBP-1c) promoter through the combinatorial actions of SREBP, LXR, Sp-1 and NF-Y cis-acting elements, Biochem J, 385, S207, 10.1042/BJ20040162 · DOI
  48. Sinal, 2000, Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid ho-meostasis, Cell, 102, S731, 10.1016/S0092-8674(00)00062-3 · DOI · Paper page
  49. Zhang, 2006, Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice, Proc Natl Acad Sci USA, 103, S1006, 10.1073/pnas.0506982103 · DOI · Paper page
  50. Cariou, 2006, The expanding role of the bile acid receptor FXR in the small intestine, J Hepatol, 44, S1213, 10.1016/j.jhep.2006.03.006 · DOI
  51. Watanabe, 2004, Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c, J Clin Invest, 113, S1408, 10.1172/JCI21025 · DOI · Paper page
  52. Hirokane, 2004, Bile acid reduces the secretion of very low density lipoprotein by repressing microsomal triglyceride transfer protein gene expression mediated by hepatocyte nuclear factor-4, J Biol Chem, 279, S45685, 10.1074/jbc.M404255200 · DOI · Paper page
  53. Bilz, 2006, Activation of the farnesoid X receptor improves lipid metabolism in combined hyperlipid-emic hamsters, Am J Physiol Endocrinol Metab, 290, SE716, 10.1152/ajpendo.00355.2005 · DOI
  54. Yamashita, 2001, A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver, Proc Natl Acad Sci USA, 98, S9116, 10.1073/pnas.161284298 · DOI · Paper page
  55. Dentin, 2006, Hepatic gene regulation by glucose and polyunsaturated fatty acids: a role for ChREBP, J Nutr, 136, S1145, 10.1093/jn/136.5.1145 · DOI
  56. Federico, 2006, Intestinal insulin resistance and aberrant production of apoli-poprotein B48 lipoproteins in an animal model of insulin resistance and metabolic dyslipidemia: evidence for activation of protein tyrosine phospha-tase-1B, extracellular signal-related kinase, and sterol regulatory element-binding protein-1c in the fructose-fed hamster intestine, Diabetes, 55, S1316, 10.2337/db04-1084 · DOI
  57. Dentin, 2005, Carbohydrate responsive element binding protein (ChREBP) and sterol regulatory element binding protein-1c (SREBP-1c):two key regulators of glucose metabolism and lipid synthesis in liver, Biochimie, 87, S81, 10.1016/j.biochi.2004.11.008 · DOI · Paper page
  58. Zoltowska, 2001, Circulating lipoproteins and hepatic sterol metabolism in Psam-momys obesus prone to obesity, hyperglycemia and hyperinsulinemia, Atherosclerosis, 157, S85, 10.1016/S0021-9150(00)00711-5 · DOI
  59. Sullivan, 1993, The gerbil, hamster, and guinea pig as rodent models for hyperlipidemia, Lab Anim Sci, 43, S575
  60. Nistor, 1987, The hyperlipid-emic hamster as a model of experimental atherosclerosis, Atherosclerosis, 68, S159, 10.1016/0021-9150(87)90106-7 · DOI · Paper page
  61. Carpentier, 2002, Ameliorated hepatic insulin resistance is associated with normalization of microsomal triglyceride transfer protein expression and reduction in very low density lipoprotein assembly and secretion in the fructose-fed hamster, J Biol Chem, 277, S28795, 10.1074/jbc.M204568200 · DOI

Cited by

See all 240

Metadata

Authors
Rutledge, A. C., & Adeli, K.
Venue
Nutrition Reviews
Published
2008-06-28
Volume
65
Issue
6 Pt 2
Pages
S13-S23
ISSN
0029-6643 (ISSN-L)
OpenAlex
W2150126813
Cited by
240
References
11
FWCI
13.51
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Fructose and the Metabolic Syndrome: Pathophysiology and Molecular Mechanisms. https://app.cochat.ai/papers/10.1111/j.1753-4887.2007.tb00322.x
The paper
Rutledge, A. C., & Adeli, K. (2008). Fructose and the Metabolic Syndrome: Pathophysiology and Molecular Mechanisms. Nutrition Reviews. https://doi.org/10.1111/j.1753-4887.2007.tb00322.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.